October 23, 2007 - Hologic Inc. and Cytyc Corp. announced the completion of the combination of the two companies, reportedly creating one of the largest companies in the world focused on advanced technology in women's health.
Under the terms of the merger agreement, Cytyc shareholders received 0.52 shares of Hologic common stock and $16.50 in cash for each share of Cytyc common stock held by them, with aggregate consideration paid to Cytyc shareholders totaling approximately $6.2 billion, payable in approximately 65,800,000 shares of Hologic common stock and approximately $2.1 billion in cash.
Hologic will continue to trade on the Nasdaq Global Select Market under the symbol "HOLX" while Cytyc will become a wholly-owned subsidiary of Hologic and will cease trading on the NASDAQ as of the close of trading on October 22, 2007.
For more information: www.cytyc.com and www.hologic.com www.cytyc.com